InsiderTrades

Form 4 for NXDT NEXPOINT DIVERSIFIED REAL ESTATE TRUST

Accepted 2024-01-17 00:00:00 ET · period of report 2024-01-12 · accession 0001437749-24-001561 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
MI 2024-01-17 2024-01-12 NXDT DONDERO JAMES D See Remarks, Dir, 10% J - Other — +169.9K 540.7K +46% —

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-01-12 J A 56,455.49 — 597,203.68 I See Footnote — — (F5) Under the terms of the Advisory Agreement, the Adviser may elect to receive payment for a portion of its monthly fees under the Advisory Agreement in common shares of the Company. Such common shares received as payment are valued at the VWAP of the shares for the 10 trading days prior to the end of the month for which such fees will be paid. The Company issued 56,455.49 common shares to the Adviser as payment of its fees for the month of December at a VWAP of $7.9779. (F3) 32,082 shares are held by Drugcrafters, L.P. ("Drugcrafters"), 69,294.07 shares are held by PCMG Trading Partners XXIII, L.P., 180,159 shares are held by Governance Re Ltd. and 315,668.61 shares (following the acquisitions described herein) are held by the Adviser. Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
2 Common Common Stock 2024-01-12 J A 57,847.68 — 485,130.74 I See Footnote — — (F1) Under the terms of the Advisory Agreement, dated July 1, 2022, by and between NexPoint Diversified Real Estate Trust (the "Company") and NexPoint Real Estate Advisers X, L.P. (the "Adviser"), as amended by that First Amendment to Advisory Agreement dated October 25, 2022, and as amended by that Second Amendment to Advisory Agreement, dated April 11, 2023 (the "Advisory Agreement"), the Adviser may elect to receive payment for a portion of its monthly fees under the Advisory Agreement in common shares of the Company. Such common shares received as payment are valued at the volume-weighted average price ("VWAP") of the shares for the 10 trading days prior to the end of the month for which such fees will be paid. The Company issued 57,847.68 common shares to the Adviser as payment of its fees for the month of October at a VWAP of $7.7859 per share. (F2) Includes shares acquired under a dividend reinvestment plan. (F3) 32,082 shares are held by Drugcrafters, L.P. ("Drugcrafters"), 69,294.07 shares are held by PCMG Trading Partners XXIII, L.P., 180,159 shares are held by Governance Re Ltd. and 315,668.61 shares (following the acquisitions described herein) are held by the Adviser. Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.
3 Common Common Stock 2024-01-12 J A 55,617.45 — 540,748.19 I See Footnote — — (F4) Under the terms of the Advisory Agreement, the Adviser may elect to receive payment for a portion of its monthly fees under the Advisory Agreement in common shares of the Company. Such common shares received as payment are valued at the VWAP of the shares for the 10 trading days prior to the end of the month for which such fees will be paid. The Company issued 55,617.45 common shares to the Adviser as payment of its fees for the month of November at a VWAP of $8.2637 per share. (F3) 32,082 shares are held by Drugcrafters, L.P. ("Drugcrafters"), 69,294.07 shares are held by PCMG Trading Partners XXIII, L.P., 180,159 shares are held by Governance Re Ltd. and 315,668.61 shares (following the acquisitions described herein) are held by the Adviser. Mr. Dondero owns 75% of PCMG Trading Partners XXIII, L.P. ("PCMG") and PCMG owns 99% of Drugcrafters. These entities are ultimately controlled by Mr. Dondero. Mr. Dondero may be deemed to be an indirect beneficial owner of shares held by such entities. Mr. Dondero disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.